findmyKOL
Clinical trialNCT00733603CompletedInterventional

Physical Therapy in Women With Interstitial Cystitis

SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrollment81Interstitial CystitisPainful Bladder Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

There are many different treatments that doctors recommend for patients with IC/PBS. Only a few research studies have been done to evaluate treatments given to patients. Treatment choices can be of two types: drug therapy and non-drug therapy. The two treatments used in this study will be of the non-drug therapy type. One of the treatments being used in this study is called Myofascial Tissue Manipulation. This is a kind of physical therapy that is designed to work on specific muscles and tissue layers in a particular part of the body. In this study, this treatment will focus on the areas around the pelvis and the pelvic floor. The treatment will involve the physical therapist's use of hands and fingers to target specific muscles and tissues located within your pelvis, rectum, and/or vagina (the pelvic floor) as well as muscles and layers of tissue in your abdomen and legs. The other treatment being used in this study is Global Therapeutic Massage. This treatment involves the physical therapist's use of classic Western body massage techniques on the muscles of your arms, legs, hands, neck, shoulders, back, stomach, buttocks, and feet to create an overall feeling of well being. The purpose of this research study is to find out if Pelvic Physical Therapy is safe and effective on treating symptoms in women with interstitial cystitis as compared to a full body therapeutic massage. This study will also measure the lasting effects of the treatment up to 3 months after your last study treatment.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Queen'S University

    Kingston, Ontario, Canada

United States
  • Univeristy of California San Diego

    San Diego, California, United States

  • Stanford University Medical Center

    Stanford, California, United States

  • Loyola University Medical Center

    Maywood, Illinois, United States

  • University of Iowa Hospitals and Clinic

    Iowa City, Iowa, United States

  • University of Maryland

    Baltimore, Maryland, United States

  • Henry Ford Hospital

    Detroit, Michigan, United States

  • William Beaumont Hospital

    Royal Oak, Michigan, United States

  • University of Rochester Medical Center

    Rochester, New York, United States

  • University of Pennsylvania Health System

    Philadelphia, Pennsylvania, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2008
Primary completion
31 Dec 2009
Completion
31 Dec 2009
Last update posted
22 Mar 2021
Registered enrollment
81
Registry id
NCT00733603

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.